Investigating adverse events following immunisation with pneumococcal polysaccharide vaccine using electronic general practice data Read more about Investigating adverse events following immunisation with pneumococcal polysaccharide vaccine using electronic general practice data41 views
Long-term impact of a "3 + 0" schedule for 7- and 13-valent pneumococcal conjugate vaccines on invasive pneumococcal disease in Australia, 2002–2014 Read more about Long-term impact of a "3 + 0" schedule for 7- and 13-valent pneumococcal conjugate vaccines on invasive pneumococcal disease in Australia, 2002–201462 views
Effect of Tdap when administered before, with or after the 13-valent pneumococcal conjugate vaccine (coadministered with the quadrivalent meningococcal conjugate vaccine) in adults: a randomised controlled trial Read more about Effect of Tdap when administered before, with or after the 13-valent pneumococcal conjugate vaccine (coadministered with the quadrivalent meningococcal conjugate vaccine) in adults: a randomised controlled trial69 views
Carrier priming to improve pneumococcal disease control and reduce the international program’s cost in children [commentary] Read more about Carrier priming to improve pneumococcal disease control and reduce the international program’s cost in children [commentary]
Potential carrier priming effect in Australian infants after 7-valent pneumococcal conjugate vaccine introduction Read more about Potential carrier priming effect in Australian infants after 7-valent pneumococcal conjugate vaccine introduction2 views
Retrospective economic evaluation of childhood 7-valent pneumococcal conjugate vaccination in Australia: uncertain herd impact on pneumonia critical Read more about Retrospective economic evaluation of childhood 7-valent pneumococcal conjugate vaccination in Australia: uncertain herd impact on pneumonia critical3 views
Evaluation of impact of 23 valent pneumococcal polysaccharide vaccine following 7 valent pneumococcal conjugate vaccine in Australian Indigenous children Read more about Evaluation of impact of 23 valent pneumococcal polysaccharide vaccine following 7 valent pneumococcal conjugate vaccine in Australian Indigenous children23 views
Pneumonia in elderly Australians – reduction in presumptive pneumococcal but no change in all cause pneumonia hospitalisations post 7 valent pneumococcal conjugate vaccine Read more about Pneumonia in elderly Australians – reduction in presumptive pneumococcal but no change in all cause pneumonia hospitalisations post 7 valent pneumococcal conjugate vaccine11 views
Long term population impact of seven-valent pneumococcal conjugate vaccine with a “3+0” schedule – how do “2+1” and “3+1” schedules compare? Read more about Long term population impact of seven-valent pneumococcal conjugate vaccine with a “3+0” schedule – how do “2+1” and “3+1” schedules compare?
Evaluating the implementation of the 13-valent pneumococcal vaccine supplementary dose program in Australian primary health care settings Read more about Evaluating the implementation of the 13-valent pneumococcal vaccine supplementary dose program in Australian primary health care settings
